A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
18 04 2019
Historique:
received: 30 08 2018
revised: 18 01 2019
accepted: 04 03 2019
pubmed: 9 4 2019
medline: 16 1 2020
entrez: 9 4 2019
Statut: ppublish

Résumé

Drug resistance and relapse remain key challenges in pancreatic cancer. Here, we have used RNA sequencing (RNA-seq), chromatin immunoprecipitation (ChIP)-seq, and genome-wide CRISPR analysis to map the molecular dependencies of pancreatic cancer stem cells, highly therapy-resistant cells that preferentially drive tumorigenesis and progression. This integrated genomic approach revealed an unexpected utilization of immuno-regulatory signals by pancreatic cancer epithelial cells. In particular, the nuclear hormone receptor retinoic-acid-receptor-related orphan receptor gamma (RORγ), known to drive inflammation and T cell differentiation, was upregulated during pancreatic cancer progression, and its genetic or pharmacologic inhibition led to a striking defect in pancreatic cancer growth and a marked improvement in survival. Further, a large-scale retrospective analysis in patients revealed that RORγ expression may predict pancreatic cancer aggressiveness, as it positively correlated with advanced disease and metastasis. Collectively, these data identify an orthogonal co-option of immuno-regulatory signals by pancreatic cancer stem cells, suggesting that autoimmune drugs should be evaluated as novel treatment strategies for pancreatic cancer patients.

Identifiants

pubmed: 30955884
pii: S0092-8674(19)30272-7
doi: 10.1016/j.cell.2019.03.010
pmc: PMC6711371
mid: NIHMS1523556
pii:
doi:

Substances chimiques

Cell Adhesion Molecules 0
Nuclear Receptor Subfamily 1, Group F, Member 3 0
RNA, Small Interfering 0
Receptors, G-Protein-Coupled 0
Receptors, Interleukin-10 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

572-586.e22

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001442
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA169281
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA186043
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA155620
Pays : United States
Organisme : NCI NIH HHS
ID : F31 CA206416
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007752
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA197699
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM119850
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL086344
Pays : United States
Organisme : Cancer Research UK
ID : C10652-A16566
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

J Immunol Methods. 2009 Aug 15;347(1-2):70-8
pubmed: 19567251
PLoS One. 2013 Sep 17;8(9):e73968
pubmed: 24069258
Cell. 2015 May 21;161(5):1202-1214
pubmed: 26000488
Cell. 2015 Jan 15;160(1-2):324-38
pubmed: 25557080
Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):12962-7
pubmed: 26438849
BMC Bioinformatics. 2010 May 11;11:237
pubmed: 20459804
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
PLoS One. 2015 May 28;10(5):e0126522
pubmed: 26020648
Bioinformatics. 2018 Jan 1;34(1):126-128
pubmed: 28968701
Cancer Cell. 2014 Dec 8;26(6):896-908
pubmed: 25464900
Nat Rev Drug Discov. 2011 Jan;10(1):47-60
pubmed: 21193867
Nat Methods. 2017 Jul;14(7):687-690
pubmed: 28581496
Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52
pubmed: 25352553
Sci Rep. 2017 Nov 20;7(1):15854
pubmed: 29158538
Cell. 2012 Sep 14;150(6):1274-86
pubmed: 22959076
Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):E2486-95
pubmed: 22908270
Gastroenterology. 2011 Dec;141(6):2218-2227.e5
pubmed: 21864475
Nat Med. 2016 May;22(5):488-96
pubmed: 27019329
Genome Biol. 2017 Mar 28;18(1):58
pubmed: 28351383
ACS Chem Biol. 2012 Apr 20;7(4):672-7
pubmed: 22292739
Nat Genet. 2002 Sep;32(1):128-34
pubmed: 12185368
J Virol. 1998 Nov;72(11):8463-71
pubmed: 9765382
Nat Biotechnol. 2016 May;34(5):525-7
pubmed: 27043002
Cancer Cell. 2004 Apr;5(4):375-87
pubmed: 15093544
Nat Protoc. 2012 Mar 01;7(3):562-78
pubmed: 22383036
Int J Cancer. 1980 May 15;25(5):591-8
pubmed: 6989766
N Engl J Med. 2011 May 12;364(19):1817-25
pubmed: 21561347
Nucleic Acids Res. 2017 Jul 3;45(W1):W130-W137
pubmed: 28472511
Eur J Immunol. 2012 Sep;42(9):2232-7
pubmed: 22949321
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Nature. 2016 Mar 3;531(7592):47-52
pubmed: 26909576
Toxicol Appl Pharmacol. 2011 Aug 15;255(1):94-102
pubmed: 21703291
Genet Epidemiol. 2002 Jun;23(1):70-86
pubmed: 12112249
J Natl Cancer Inst. 2010 Mar 3;102(5):340-51
pubmed: 20164446
Cell Mol Life Sci. 2017 Jul;74(14):2569-2586
pubmed: 28258292
J Virol Methods. 2004 Dec 15;122(2):131-9
pubmed: 15542136
Cell. 2013 Nov 7;155(4):934-47
pubmed: 24119843
Genome Biol. 2014;15(12):554
pubmed: 25476604
Cold Spring Harb Perspect Biol. 2019 Feb 1;11(2):
pubmed: 29038121
Clin Cancer Res. 2018 Sep 15;24(18):4444-4454
pubmed: 29661773
Genome Biol. 2010;11(10):R106
pubmed: 20979621
PLoS Comput Biol. 2010 Jan 15;6(1):e1000641
pubmed: 20090828
Cell. 2013 Apr 11;153(2):307-19
pubmed: 23582322
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Cell Stem Cell. 2007 Sep 13;1(3):313-23
pubmed: 18371365
Expert Opin Ther Pat. 2016 Jun;26(6):737-44
pubmed: 26895086
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
Nucl Receptor Res. 2015;2:
pubmed: 26878025
Cell Rep. 2017 Feb 21;18(8):1946-1957
pubmed: 28228260
Cell. 2004 Dec 17;119(6):847-60
pubmed: 15607980
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Bioinformatics. 2009 Aug 1;25(15):1952-8
pubmed: 19505939
Hum Pathol. 2009 Feb;40(2):189-98
pubmed: 18799194
BMC Bioinformatics. 2013 Jan 16;14:7
pubmed: 23323831
Nature. 2001 Nov 1;414(6859):105-11
pubmed: 11689955
Nature. 2016 Jun 06;534(7607):407-411
pubmed: 27281208
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):75-80
pubmed: 20018761
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Cancer Res. 2007 Feb 1;67(3):1030-7
pubmed: 17283135
Cancer Cell. 2003 Dec;4(6):437-50
pubmed: 14706336
Cancer Cell. 2012 Dec 11;22(6):737-50
pubmed: 23201164
Cell. 2006 Sep 22;126(6):1121-33
pubmed: 16990136
Gastroenterology. 2014 Jan;146(1):245-56
pubmed: 24096005

Auteurs

Nikki K Lytle (NK)

Department of Pharmacology, University of California, San Diego School of Medicine, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA.

L Paige Ferguson (LP)

Department of Pharmacology, University of California, San Diego School of Medicine, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA.

Nirakar Rajbhandari (N)

Department of Pharmacology, University of California, San Diego School of Medicine, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA.

Kathryn Gilroy (K)

Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1BD, UK.

Raymond G Fox (RG)

Department of Pharmacology, University of California, San Diego School of Medicine, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA.

Anagha Deshpande (A)

Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

Christian M Schürch (CM)

Baxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, Stanford University School of Medicine, 269 Campus Drive, Stanford, CA, USA.

Michael Hamilton (M)

Department of Pharmacology, University of California, San Diego School of Medicine, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA.

Neil Robertson (N)

Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1BD, UK.

Wei Lin (W)

Molecular Medicine Division, The Translational Genomics Research Institute, Phoenix, AZ, USA.

Pawan Noel (P)

Molecular Medicine Division, The Translational Genomics Research Institute, Phoenix, AZ, USA.

Martin Wartenberg (M)

Institute of Pathology, University of Bern, Murtenstrasse 31, 3008 Bern, Switzerland.

Inti Zlobec (I)

Institute of Pathology, University of Bern, Murtenstrasse 31, 3008 Bern, Switzerland.

Micha Eichmann (M)

Institute of Pathology, University of Bern, Murtenstrasse 31, 3008 Bern, Switzerland.

José A Galván (JA)

Institute of Pathology, University of Bern, Murtenstrasse 31, 3008 Bern, Switzerland.

Eva Karamitopoulou (E)

Institute of Pathology, University of Bern, Murtenstrasse 31, 3008 Bern, Switzerland.

Tami Gilderman (T)

Department of Pharmacology, University of California, San Diego School of Medicine, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA.

Lourdes Adriana Esparza (LA)

Department of Pharmacology, University of California, San Diego School of Medicine, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA.

Yutaka Shima (Y)

Department of Pharmacology, University of California, San Diego School of Medicine, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA.

Philipp Spahn (P)

Department of Pediatrics and the Novo Nordisk Foundation Center for Biosustainability, University of California, San Diego School of Medicine, La Jolla, CA, USA.

Randall French (R)

Moores Cancer Center, University of California, San Diego School of Medicine, La Jolla, CA, USA.

Nathan E Lewis (NE)

Department of Pediatrics and the Novo Nordisk Foundation Center for Biosustainability, University of California, San Diego School of Medicine, La Jolla, CA, USA.

Kathleen M Fisch (KM)

Center for Computational Biology and Bioinformatics, University of California, San Diego School of Medicine, La Jolla, CA, USA.

Roman Sasik (R)

Center for Computational Biology and Bioinformatics, University of California, San Diego School of Medicine, La Jolla, CA, USA.

Sara Brin Rosenthal (SB)

Center for Computational Biology and Bioinformatics, University of California, San Diego School of Medicine, La Jolla, CA, USA.

Marcie Kritzik (M)

Department of Pharmacology, University of California, San Diego School of Medicine, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA.

Daniel Von Hoff (D)

Molecular Medicine Division, The Translational Genomics Research Institute, Phoenix, AZ, USA.

Haiyong Han (H)

Molecular Medicine Division, The Translational Genomics Research Institute, Phoenix, AZ, USA.

Trey Ideker (T)

Moores Cancer Center, University of California, San Diego School of Medicine, La Jolla, CA, USA; Department of Medicine, University of California, San Diego School of Medicine, La Jolla, CA, USA.

Aniruddha J Deshpande (AJ)

Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

Andrew M Lowy (AM)

Moores Cancer Center, University of California, San Diego School of Medicine, La Jolla, CA, USA; Division of Surgical Oncology, Department of Surgery, University of California, San Diego School of Medicine, La Jolla, CA, USA.

Peter D Adams (PD)

Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1BD, UK; Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

Tannishtha Reya (T)

Department of Pharmacology, University of California, San Diego School of Medicine, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA; Moores Cancer Center, University of California, San Diego School of Medicine, La Jolla, CA, USA; Department of Medicine, University of California, San Diego School of Medicine, La Jolla, CA, USA. Electronic address: treya@ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH